Solid Biosciences reported Q3 2026 earnings and issued a business update, though no financial details were disclosed in the announcement. Recent milestones incl

BWB News TV • 2026-11-04 21:22 UTC • By Billy Odell Tucker-Robinson

Solid Biosciences reported Q3 2026 earnings and issued a business update, though no financial details were disclosed in the announcement. Recent milestones include ESGCT2026 Duchenne data, EU orphan status for SGT-212 and five patients dosed in FALCON.

Share this article

𝕏 X / Twitter Facebook LinkedIn WhatsApp

📚 More from Billy’s World

📰 Banking With Billy News All breaking financial news & market analysis 📚 Banking With Billy Books Deep-dive books on every financial story 💬 Join the Community discord.gg/VHxwmR5j4Y 🎥 Banking With Billy on YouTube Live streams & market commentary

Banking With Billy News Network — bankingwithbilly.com
Discord: discord.gg/VHxwmR5j4Y • YouTube: @BankingWithBilly